| 前收市價 | 48.51 |
| 開市 | 48.45 |
| 買盤 | 48.37 x 900 |
| 賣出價 | 48.39 x 1200 |
| 今日波幅 | 48.24 - 48.58 |
| 52 週波幅 | 47.58 - 70.94 |
| 成交量 | |
| 平均成交量 | 16,033,827 |
| 市值 | 98.217B |
| Beta 值 (5 年，每月) | 0.39 |
| 市盈率 (最近 12 個月) | 12.55 |
| 每股盈利 (最近 12 個月) | 3.86 |
| 業績公佈日 | 2024年4月25日 |
| 遠期股息及收益率 | 2.40 (4.95%) |
| 除息日 | 2024年4月04日 |
| 1 年預測目標價 | 55.95 |
ZacksBristol Myers Squibb (BMY) Advances While Market Declines: Some Information for Investors
Bristol Myers Squibb (BMY) closed the most recent trading day at $48.51, moving +0.48% from the previous trading session.
Motley FoolBetter Buy: Bristol Myers Squibb or the Vanguard S&P 500 ETF?
Bristol Myers Squibb stock sports an attractive valuation and dividend yield. Is it a more compelling buy than the Vanguard S&P 500 ETF?
ZacksThe Zacks Analyst Blog Highlights Bristol Myers, Moderna, 2seventy bio, Amylyx Pharmaceuticals and Syros Pharmaceuticals
Bristol Myers, Moderna, 2seventy bio, Amylyx Pharmaceuticals and Syros Pharmaceuticals are part of the Zacks top Analyst Blog.
